Literature DB >> 4826029

Criteria for the assessment of reversibility in airways obstruction. Report of the Committee on Emphysema American College of Chest Physicians.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4826029     DOI： 10.1378/chest.65.5.552

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  10 in total

1.  Soluble L-Selectin as an Independent Biomarker of Bronchial Asthma.

Authors:  Ebrahim Nadi; Mehrdad Hajilooi; Saeed Pajouhan; Mehran Haidari
Journal:  J Clin Lab Anal       Date:  2014-05-05       Impact factor: 2.352

2.  Terbutaline in COPD comparison between Turbuhaler and chlorofluorocarbon (CFC) inhaler.

Authors:  H Formgren; A Sjökvist; E Ståhl; J E Wirén
Journal:  Lung       Date:  1994       Impact factor: 2.584

3.  Radiological correlates and clinical implications of the paradoxical lung function response to β₂ agonists: an observational study.

Authors:  Surya P Bhatt; James M Wells; Victor Kim; Gerard J Criner; Craig P Hersh; Megan Hardin; William C Bailey; Hrudaya Nath; Young-Il Kim; Marilyn G Foreman; Douglas S Stinson; Carla G Wilson; Stephen I Rennard; Edwin K Silverman; Barry J Make; Mark T Dransfield
Journal:  Lancet Respir Med       Date:  2014-09-09       Impact factor: 30.700

4.  Assessing bronchodilator response by changes in per cent predicted forced expiratory volume in one second.

Authors:  Octavian C Ioachimescu; Jose A Ramos; Michael Hoffman; Kevin McCarthy; James K Stoller
Journal:  J Investig Med       Date:  2021-02-11       Impact factor: 2.895

5.  Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study.

Authors:  Wan C Tan; William M Vollmer; Bernd Lamprecht; David M Mannino; Anamika Jithoo; Ewa Nizankowska-Mogilnicka; Filip Mejza; Thorarinn Gislason; Peter G J Burney; A Sonia Buist
Journal:  Thorax       Date:  2012-04-29       Impact factor: 9.139

6.  Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial.

Authors:  Nicola A Hanania; Amir Sharafkhaneh; Bartolome Celli; Marc Decramer; Ted Lystig; Steven Kesten; Donald Tashkin
Journal:  Respir Res       Date:  2011-01-11

7.  A New Bronchodilator Response Grading Strategy Identifies Distinct Patient Populations.

Authors:  James E Hansen; Asli G Dilektasli; Janos Porszasz; William W Stringer; Youngju Pak; Harry B Rossiter; Richard Casaburi
Journal:  Ann Am Thorac Soc       Date:  2019-12

8.  Which bronchodilator reversibility criteria can predict severe acute exacerbation in chronic obstructive pulmonary disease patients?

Authors:  Junghyun Kim; Woo Jin Kim; Chang-Hoon Lee; Sang Haak Lee; Myung-Goo Lee; Kyeong-Cheol Shin; Kwang Ha Yoo; Ji-Hyun Lee; Seong Yong Lim; Ju Ock Na; Hun-Gyu Hwang; Yoonki Hong; Myoung Nam Lim; Chul-Gyu Yoo; Ki Suck Jung; Sang-Do Lee
Journal:  Respir Res       Date:  2017-05-30

9.  Bronchodilator reversibility as a diagnostic test for adult asthma: findings from the population-based Tasmanian Longitudinal Health Study.

Authors:  Daniel J Tan; Caroline J Lodge; Adrian J Lowe; Dinh S Bui; Gayan Bowatte; David P Johns; Garun S Hamilton; Paul S Thomas; Michael J Abramson; E Haydn Walters; Jennifer L Perret; Shyamali C Dharmage
Journal:  ERJ Open Res       Date:  2021-02-08

10.  On a New Approach to Assess Bronchodilator Responsiveness.

Authors:  Octavian C Ioachimescu
Journal:  Ann Am Thorac Soc       Date:  2021-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.